课题基金 / 基金详情

Analysis of the mechanism of renal injury at molecular levels by application of monoclonal antibodies

Analysis of the mechanism of renal injury at molecular levels by application of monoclonal antibodies
应用单克隆抗体从分子水平分析肾损伤机制
批准号:
03454168
负责人:
SHIMIZU Fujio
金额:
$4.29万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1991
资助国家:
日本
项目状态:
已结题
起止时间:
1991 至 1992

项目摘要

项目成果

SHIMIZU Fujio的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Both proteinuria-inducing monoclonal antibodies (mAb) 1-22-3 and 5-1-6 are very valuable tools for analyzing the mechanism of renal injury at the molecular or epitope levels. These mAbs could induce renal lesions with extraordinary small amounts, much smaller than the previously reported minimum dose in the various experimental glomerulonephritides. Such a small amount of mAb to induce proteinuria, suggests that the recognized antigen must be limited to a critical site important in regulating the permeability of the glomerular capillary wall.In order to purify the corresponding antigen, isolated glomeruli have been labeled with 125-I by Bolton-Hunter method. Combined with gene cloning characterization of the corresponding antigen is now in progress.Not Fab but F(ab)2 as well as whole molecule of 5-1-6 could induce proteinuria. Cross-linking of the antigenic molecules on the glomerular epithelial cell surface followed by endocytosis seems to be the process, which is necessary for induction of proteinuria. Such a kinetics was investigated in vitro using isolated glomeruli by applying the various chemical agents, such as NaN3, Cyto- chalasin B or Ca-ionophore. Thus this process was demonstrated to be energy- dependent. Details will be examined further also on the signal transduction system leading to proteinuria.We have succeeded in inducing irreversible mesangial sclerotic changes with persistent proteinuria by a second injection of mAb 1-22-3 at two weeks after the first injection. It is a very valuable model for investigating the mechanism of chronic progression of human mesangial proliferative glomerulonephritis.
期刊论文(142)
专著(0)
科研奖励(0)
会议论文
Orikasa,M.: "Establishment of murine macrophage-like mutant and hybrid cell lines:comparative analysis of the differentiation induced by 1,25-dihydroxy vitamin D3 and recombinant murine interferon-γ." Cell.Immunol.132. 350-365 (1991)
Orikasa, M.:“鼠巨噬细胞样突变体和杂交细胞系的建立:1,25-二羟基维生素 D3 和重组鼠干扰素-γ 诱导分化的比较分析。Cell.Immunol.132。” 1991)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kagami,S.: "A monoclonal antibody(IG10)recognizes a novel human mesangial antigen" Kidney Int.42. 700-709 (1992)
Kagami,S.:“单克隆抗体(IG10)识别一种新型人类系膜抗原”Kidney Int.42。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
清水 不二雄(分担執筆): "病理学キーワード" 文光堂, 424 (1991)
清水富士夫(撰稿人):《病理学关键词》Bunkodo,424(1991)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
53
    Relaxation-less control of atomic motion and its applications to atom-optics
    • 批准号:
      22540408
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2010
    • 负责人:
      SHIMIZU Fujio
    • 依托单位:
    Identification and regulation of factors related to progression of renal
    • 批准号:
      15390268
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.47万
    • 财政年份:
      2003
    • 负责人:
      SHIMIZU Fujio
    • 依托单位:
    Analysis on the mechanism of proteinuria induced by glomerular epithelial cell lesions
    • 批准号:
      13470210
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $3.71万
    • 财政年份:
      2001
    • 负责人:
      SHIMIZU Fujio
    • 依托单位:
    Physics and Applications of Laser Cooling (The Blanket Group)
    • 批准号:
      11216101
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $16.26万
    • 财政年份:
      1999
    • 负责人:
      SHIMIZU Fujio
    • 依托单位:
    国内基金
    海外基金
    足细胞中补体系统活化以及在足细胞损伤中作用机制研究
    • 批准号:
      81170657
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2011
    • 负责人:
      丁洁
    • 依托单位:
    蛋白尿时肾小球足细胞"重塑"的作用分子及分子机制研究
    • 批准号:
      30830105
    • 项目类别:
      重点项目
    • 资助金额:
      185.0万元
    • 批准年份:
      2008
    • 负责人:
      丁洁
    • 依托单位:
    从离子通道蛋白TRPC6角度探讨突变podocin致足细胞损伤的分子机制
    • 批准号:
      30801250
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      21.0万元
    • 批准年份:
      2008
    • 负责人:
      范青锋
    • 依托单位: